Current Progress in Cancer Immunotherapies Using Small Molecules Targeting PD-L1 Stability
Abstract
Open Access
ISSN 2577-5790
© 2021 by the authors; CC BY 4.0 licence
OBM Genetics , Volume 5 , Issue 1 (2021)
Pages: 85
Published: April 2021
(This book is a printed edition that was published in OBM Genetics)
PD-L1 is an immune checkpoint protein frequently overexpressed in tumors for immune escape. Therefore, targeting PD-L1 presents a promising avenue for immunotherapies. However, current monoclonal antibody-based therapies have poor overall response rates. In this review, we summarize the current progress on development of small molecules targeting PD-L1 stability for immunotherapy. View this paper.
Volume 5,Issue 1
Current Progress in Cancer Immunotherapies Using Small Molecules Targeting PD-L1 StabilityAbstract PD-L1 is an immune checkpoint protein that is frequently overexpressed by the cells in the tumor microenvironment. PD-L1 binds to PD-1 present on the activated antitumor T-cells, which allows for tumor immune escape. The ability of the PD-1/PD-L1 axis to suppress antitumor immunity enables its application as a potential target for small-molecule-based immunotherapies. Targeting the PD-L1-mediated tumor immune evasion represents a promising approach for immune checkpoint blockade therapies. Howev [...] |
Development of a Novel Pipette Tip-Aided Cell Cloning Method for The Effective Isolation of Genome-Edited Porcine CellAbstract Direct colony cloning of adherent mammalian cells using rings or dilution cloning has been used frequently for obtaining stable transfectants after gene delivery. As an alternative to these methods, successful isolation of the cells in a single colony is possible by placing a trypsin-immersed small paper disk onto the colony and subsequently picking up the paper with the assumption that it carries the trypsinized cells. However, the cloning success using this technique largely relies on the cell [...] |
Translating RNA Splicing Analysis into Diagnosis and Therapyby
Andrew G.L. Douglas
and
Diana Baralle
Abstract A large proportion of rare disease patients remain undiagnosed and the vast majority of such conditions remain untreatable whether diagnosed or not. RNA splicing analysis is able to increase the diagnostic rate in rare disease by identifying cryptic splicing mutations and can help in interpreting the pathogenicity of genomic variants. Whilst targeted RT-PCR analysis remains a highly sensitive tool for assessing the splicing effects of known variants, RNA-seq can provide a more comprehensive tran [...] |
Genomic Analysis for Citrus Disease Detectionby
Mohamed Abutineh
,
Nicholas Pizzo
,
Nicholas Nifakos
,
Xiao-Lu Jin
,
John M Harlin
and
Xing-Hai Zhang
Abstract Citrus is an important group of globally produced fruit crops, holding great economic, cultural, and health value. Belonging to the Rutacaeae family, the genus Citrus includes some of the most iconic and widely appreciated variants of fruits such as the orange, lemon, lime, grapefruit, and tangerine. The spread of various diseases threatens the worldwide production of citrus fruit crops. Diseases such as Asiatic citrus canker, citrus tristeza virus, citrus leprosis, and especially citrus greenin [...] |
In vitro Electroporation in the Presence of CRISPR/Cas9 Reagents as a Safe and Effective Method for Producing Biallelic Knock-Out Porcine EmbryosAbstract The production of genetically modified (GM) pigs is considered valuable in biomedical research for the development of model animals for various diseases and pigs with resistance against viral infection. The porcine genome may be modified using several methods, such as somatic cell nuclear transfer (SCNT) using GM cells as the SCNT donor, direct injection of the transgene or the genome editing components (GEC) into fertilized eggs referred to as zygotes, the in vitro electroporation (EP) of the z [...] |
Acknowlegement to Reviewers of OBM Genetics in 2020Abstract The editors of OBM Genetics would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2020. We greatly appreciate the contribution of expert reviewers, which is crucial to the journal's editorial process. We aim to recognize reviewer contributions through several mechanisms, of which the annual publication of reviewer names is one. Reviewers receive a voucher entitling them to a discount on their next LIDSEN publication [...] |
TOP